Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin’s lymphoma

BACKGROUND: The regimen of cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP) is an efficient treatment of non-Hodgkin’s lymphoma (NHL). This study aimed to assess the efficacy and toxicity of dose-adjusted CHOP alone or in combination with rituximab (R-CHOP) by examining the stem c...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yuankai, Zhou, Ping, Han, Xiaohong, He, Xiaohui, Zhou, Shengyu, Liu, Peng, Yang, Jianliang, Zhang, Changgong, Gui, Lin, Qin, Yan, Yang, Sheng, Zhao, Liya, Yao, Jiarui, Zhang, Shuxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593367/
https://www.ncbi.nlm.nih.gov/pubmed/26370464
http://dx.doi.org/10.1186/s40880-015-0045-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593367/
https://www.ncbi.nlm.nih.gov/pubmed/26370464
http://dx.doi.org/10.1186/s40880-015-0045-3

Ejemplares similares